Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The interferon (IFN)-gamma-mediated induction of indoleamine 2,3-dioxygenase (IDO) enzyme, which converts tryptophan into N-formylkynurenine, has been implicated in the inhibition of intracellular pathogens, e.g. Toxoplasma gondii and
Chlamydia
psittaci, and in the antiproliferative effect of IFN-gamma on tumor cells. The IDO activity is induced strongly in many cell types by IFN-gamma but rather poorly by IFN-alpha or -beta. A genomic DNA clone containing part of the transcribed region of the IDO gene and approximately 13 kilobases (kb) of the 5'-upstream DNA sequence was isolated and analyzed. An approximately 1.4-kb fragment of this clone, containing 329 nucleotides of the transcribed sequence and approximately 1.1 kb of the 5'-upstream sequence, when ligated to
chloramphenicol acetyltransferase
(
CAT
) structural gene made its expression inducible by IFN-gamma, but this construct responded poorly, if at all, to IFN-alpha 2. Deletion constructs derived from this plasmid narrowed down the IFN-gamma-responsive region to a 151-nucleotide segment (-495/-344) which also contained a 14-nucleotide sequence (GGTTTCAGTTTTCC) highly homologous to the IFN(alpha)-stimulated response element (ISRE) that has been found so far in all cellular genes inducible with IFN-alpha or -beta. Expression of
CAT
activity was stimulated by IFN-gamma more effectively than by IFN-alpha 2 when a 155-nucleotide fragment (-495/-340) containing the 151-nucleotide segment required for IFN-gamma response was inserted before herpes simplex virus thymidine kinase promoter linked to
CAT
structural gene. The results indicate that despite the presence of an ISRE, the control region of the IDO gene can distinguish between IFN-gamma and IFN-alpha. This may account for the differential activation of IDO gene expression by IFN-gamma as against IFN-alpha or -beta in intact cells, and suggests that the response of ISRE to IFN-alpha or -beta may be governed by other features in the upstream control region of this gene.
...
PMID:Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. 217 56
Electroporation was used to introduce DNA into the elementary bodies of the obligate parasitic bacterium
Chlamydia
trachomatis. The source of DNA for these experiments was the chimeric plasmid pPBW100, which was constructed from the well-characterized 7.5-kb plasmid of C. trachomatis and the Escherichia coli plasmid pBGS9. To select directly for C. trachomatis carrying pPBW100, an in-frame gene fusion between the chlamydial promoter P7248 and a promoterless
chloramphenicol acetyltransferase
(cat) cassette was incorporated into the plasmid. After infection of McCoy cells with electroporated elementary bodies containing pPBW100, the following were observed: (i) the plasmid DNA was detected inside the chloramphenicol-resistant chlamydial inclusions by in situ and Southern hybridization analyses; (ii) both physical and biochemical evidence showed that
chloramphenicol acetyltransferase
was synthesized by the electroporated C. trachomatis; (iii) expression of P7248::cat was developmentally regulated and occurred during the early stages of chlamydial reticulate body development; and (iv) although the expression from P7248::cat was mainly transient, there were rare instances where chloramphenicol-resistant C. trachomatis were observed after four passages.
...
PMID:Expression of recombinant DNA introduced into Chlamydia trachomatis by electroporation. 807 53
We demonstrate the genetic transformation of
Chlamydia
pneumoniae
using a plasmid shuttle vector system which generates stable transformants. The equine
C. pneumoniae
N16 isolate harbors the 7.5-kb plasmid pCpnE1. We constructed the plasmid vector pRSGFPCAT-Cpn containing a pCpnE1 backbone, plus the red-shifted green fluorescent protein (RSGFP), as well as the
chloramphenicol acetyltransferase
(
CAT
) gene used for the selection of plasmid shuttle vector-bearing
C. pneumoniae
transformants. Using the pRSGFPCAT-Cpn plasmid construct, expression of RSGFP in koala isolate
C. pneumoniae
LPCoLN was demonstrated. Furthermore, we discovered that the human cardiovascular isolate
C. pneumoniae
CV-6 and the human community-acquired pneumonia-associated
C. pneumoniae
IOL-207 could also be transformed with pRSGFPCAT-Cpn. In previous studies, it was shown that
Chlamydia
spp. cannot be transformed when the plasmid shuttle vector is constructed from a different plasmid backbone to the homologous species. Accordingly, we confirmed that pRSGFPCAT-Cpn could not cross the species barrier in plasmid-bearing and plasmid-free
C. trachomatis
,
C. muridarum
,
C. caviae
,
C. pecorum
, and
C. abortus
However, contrary to our expectation, pRSGFPCAT-Cpn did transform
C. felis
Furthermore, pRSGFPCAT-Cpn did not recombine with the wild-type plasmid of
C. felis
Taken together, we provide for the first time an easy-to-handle transformation protocol for
C. pneumoniae
that results in stable transformants. In addition, the vector can cross the species barrier to
C. felis
, indicating the potential of horizontal pathogenic gene transfer via a plasmid.
IMPORTANCE
The absence of tools for the genetic manipulation of
C. pneumoniae
has hampered research into all aspects of its biology. In this study, we established a novel reproducible method for
C. pneumoniae
transformation based on a plasmid shuttle vector system. We constructed a
C. pneumoniae
plasmid backbone shuttle vector, pRSGFPCAT-Cpn. The construct expresses the red-shifted green fluorescent protein (RSGFP) fused to
chloramphenicol acetyltransferase
in
C. pneumoniae
C. pneumoniae
transformants stably retained pRSGFPCAT-Cpn and expressed RSGFP in epithelial cells, even in the absence of chloramphenicol. The successful transformation in
C. pneumoniae
using pRSGFPCAT-Cpn will advance the field of chlamydial genetics and is a promising new approach to investigate gene functions in
C. pneumoniae
biology. In addition, we demonstrated that pRSGFPCAT-Cpn overcame the plasmid species barrier without the need for recombination with an endogenous plasmid, indicating the potential probability of horizontal chlamydial pathogenic gene transfer by plasmids between chlamydial species.
...
PMID:The Genetic Transformation of Chlamydia pneumoniae. 3030 18